Integrated metabolomics and network pharmacology to reveal the lipid‐lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats
Journal of the Science of Food and Agriculture · 2024
DOI: 10.1002/jsfa.13213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, 2024. Verfasst von Liang Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Hyperlipidemias, Drugs, Chinese Herbal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Basic Construction Funds within the budget of Jilin Province in 2020.
Abstract (Originalsprache)
BACKGROUND Qizha Shuangye granules (QSG) comprise six traditional Chinese herbal medicines (TCHMs), which have a long history of treating hyperlipidemia (HLP) in China. This study aimed to evaluate the potential lipid‐lowering effects of QSG in an HLP rat model and investigate possible mechanisms. The HLP rat model was induced by a high‐fat diet. Lipid‐related indicators in serum were detected. Serum and liver metabolites were investigated using a liquid chromatography–mass spectrometry‐based metabolomics approach. A herb–compound–target–metabolite (H‐C‐T‐M) network was further constructed to reveal the possible molecular mechanism of QSG to alleviate HLP. RESULTS The administration of QSG inhibited the HLP‐induced changes in total cholesterol, triglyceride, low‐density lipoprotein cholesterol, high‐density lipoprotein cholesterol, and non‐esterified fatty acid (NEFA) levels. Additionally, QSG significantly attenuated the liver histopathological changes induced by HLP. Metabolomic analysis showed the serum and liver metabolic disorders presented in HLP rats. QSG can reverse the abnormal metabolism caused by HLP. Through network pharmacology analysis, key proteins such as androgen receptor, 3‐hydroxy‐3‐methylglutaryl‐CoA reductase, and peroxisome proliferator‐activated receptor‐α were screened out, and they were speculated to be possible therapeutic targets for QSG to treat HLP. CONCLUSION The present study integrated metabolomics and network pharmacology analysis to reveal the efficacy and possible mechanism of QSG in treating HLP, which provides a new reference for the research and development of QSG as a functional food. © 2023 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
- College of Pharmacy, Yanbian University, Yanji, China.
- Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.
- Key Laboratory for Analysis Methods of Active Ingredients in Traditional Chinese Medicine, Jilin Academy of Chinese Medicine Sciences, Changchun, China.
- Key Laboratory for Natural Resource of Changbai Mountain, Yanbian University, Yanji, China.
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.
ORCID-Profile: Yang Wang
Förderung
- Basic Construction Funds within the budget of Jilin Province in 2020
Zitieren
APA
Zhao, L., Wang, S., Xu, X., Guo, W., Yang, J., Liu, Y., Xie, S., Piao, G., Xu, T., Wang, Y., & Xu, Y. (2024). Integrated metabolomics and network pharmacology to reveal the lipid‐lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13213
Vancouver
Zhao L, Wang S, Xu X, Guo W, Yang J, Liu Y, et al. Integrated metabolomics and network pharmacology to reveal the lipid‐lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats. Journal of the Science of Food and Agriculture. 2024. doi:10.1002/jsfa.13213
BibTeX
@article{Zhao2024,
author = {Zhao, Liang and Wang, Shuyue and Xu, Xiaohang and Guo, Wenjun and Yang, Jingxuan and Liu, Yue and Xie, Shengxu and Piao, Guangchun and Xu, Tunhai and Wang, Yang and Xu, Yajuan},
title = {Integrated metabolomics and network pharmacology to reveal the lipid‐lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
doi = {10.1002/jsfa.13213}
}
EUVIMED